Onconova Therapeutics Announces Enrollment in Second Cohort of Phase 1 Study with ON 123300 in China
April 01, 2021 08:00 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., April 01, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
Onconova Therapeutics Announces Initiation of a Phase 1 Clinical Trial of ON 123300 in China by Partner HanX Biopharmaceuticals
September 21, 2020 08:00 ET
|
Onconova Therapeutics, Inc.
Company remains on track to file a US IND in Q4 2020, with commencement of a US Phase 1 study targeted for Q1 2021 NEWTOWN, Pa., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc....